NEWS

In our latest article, we explored an emerging alternative to fenestrated screws. However, these screws remain the most widely used solution for achieving stable fixation in osteoporotic bone. Here’s a closer look at how they work, when to use them, and what to keep in mind. As spinal surgeries increase, screw loosening—particularly in patients with poor bone quality due to … [Read more...] about (2025 Update) Fenestrated Screws in Osteoporotic Bone: The Gold Standard for Stable Spinal Fixation — What Are the Market Alternatives?

Achieving reliable pedicle screw fixation in osteoporotic bone remains one of the most persistent challenges in spine surgery. With a rapidly aging population, more patients now present with compromised bone quality due to advanced osteoporosis, pathological fractures, metastatic lesions, or prior implant failures. In these scenarios, conventional screws often fail to … [Read more...] about Fixation in Osteoporotic Bone: Is This the End of Cemented Screws?

Spineway, a specialist in innovative implants for the treatment of severe spine disorders, announces that its subsidiary Spine Innovations has received GMED (French notified body) approval for its new production line dedicated to its LP-ESP and CP-ESP intervertebral disc prostheses. This approval is a significant strategic milestone for the Group, ensuring the … [Read more...] about Spineway : GMED approval for new production line dedicated to ESP prostheses – First production of LP-ESP intervertebral disc prostheses

June 16, 2025, Morgantown, WV – After several years of litigation, Omnia and PainTEQ have fully and finally resolved all of the issues between them.  As part of that resolution PainTEQ agreed to admit that it breached the parties’ Stocking Agreement, used Omnia’s PsiF trademark, and that PainTEQ’s Gen 2 cannula infringed Omnia’s D232 design patent. Omnia and PainTEQ agree that … [Read more...] about Omnia Medical Reaches Settlement as PainTEQ Admits Breach and Patent Infringement

A newly published multicenter study in the journal Healthcare MDPI brings promising data on the use of the SiLO TFX™ posterior sacroiliac joint fusion system for patients suffering from chronic sacroiliac joint (SIJ) dysfunction. The article presents clinical and functional outcomes from multiple treatment centers and contributes valuable evidence to the growing interest in … [Read more...] about New Multicenter Study Published in Healthcare (MDPI) Highlights Clinical Outcomes of SiLO TFX™ for Chronic SI Joint Pain

Johnson & Johnson has announced that its TriALTIS™ Spine System has received CE mark approval, marking a significant step forward in its commitment to advancing spinal care through innovation, reliability, and technology. The TriALTIS™ Spine System is a next-generation posterior thoracolumbar pedicle screw system that provides a comprehensive product offering, … [Read more...] about TriALTIS™ Core System Receives CE Mark Approval

These days, it has been announced that several European Union countries support an initiative to impose a new tax on business and first-class airline tickets. Presented as an ecological measure, it aims to “offset” the higher per-passenger emissions of those flying in more spacious seats. From the outside, it may seem like a reasonable proposal. But for those of us working … [Read more...] about Eco-Taxes on Flights in Europe: Unintended Consequences in the Spine Industry

The lumbar prosthesis market, specifically lumbar total disc replacement (TDR), is experiencing significant expansion, countering the perception that it is a technique with limited or declining adoption. According to independent data from iData Research, the number of TDR procedures in the U.S. grew at a compound annual growth rate of 23% between 2018 and 2024. This growth is … [Read more...] about (2025 Update): Market, Leading FDA-Approved Devices, Material Innovations, and Competitive Landscape of Lumbar Total Disc Replacement — Which Are the Top Players?

June 28th, 2025 — This release is issued solely for informational purposes and in response to recent public discourse concerning Life Spine. Our intent is to provide fair access to all viewpoints on a matter of public interest, without endorsing, validating, or taking any position on the claims presented.Following recent media coverage and growing public interest regarding the … [Read more...] about Statement from Michael Butler Concerning Ongoing Litigation Involving Life Spine

HUNTSVILLE, Ala., June 24, 2025 (Newswire.com) - Curiteva is proud to announce FDA 510(k) clearance for the Inspire Trabecular PEEK Standalone ALIF system, the first-ever 3D printed PEEK standalone implant. This is the company's latest FDA cleared 3D Printed PEEK implant with HAFUSE technology. This milestone represents a significant leap forward in advanced medical … [Read more...] about Curiteva(R) Secures FDA 510(k) Clearance for Inspire(R) Trabecular PEEK Standalone ALIF System

Michael Butler, founder and former CEO of Life Spine, has been a prominent figure in the spinal device industry for over two decades. Known for his innovative vision and for driving one of the most dynamic companies in the field of minimally invasive spine surgery, his professional career now enters a complex new phase: a legal case brought forward by the very company he … [Read more...] about Michael Butler: From Business Success to Legal Challenge

HUNTLEY, Ill.--(BUSINESS WIRE)--Life Spine, Inc., a leading medical device company specializing in spinal surgery innovations, announced today that it has filed a lawsuit in the Circuit Court of Cook County, Illinois, against its former Chief Executive Officer, Michael Butler. In the lawsuit, Life Spine alleges that Mr. Butler wrongfully diverted hundreds of thousands of … [Read more...] about Life Spine Files Lawsuit Against Former CEO Michael Butler for Breaches of Fiduciary Duties and Contracts, Trade Secret Misappropriation, and Tortious Interference

We are pleased to announce that Global Biomedica s.r.o., a company specializing in advanced spinal solutions, has successfully obtained CE certification in accordance with the European Medical Device Regulation (EU MDR 2017/745) for its flagship product line - BMD Titanium Implant. The BMD Titanium Implant family has undergone rigorous assessment to ensure full compliance … [Read more...] about BMD Titanium Implant Products by Global Biomedica Receive CE Certification under EU MDR

The global cervical disc prosthesis market is experiencing steady growth, driven by an aging population, rising diagnoses of degenerative cervical conditions, and a growing preference for motion-preserving alternatives to traditional fusion surgery. In 2024, this segment generated approximately $2.48 billion worldwide, becoming the treatment of choice for carefully selected … [Read more...] about (2025 Update): Cervical Disc Prostheses – Global Status & Trends.Which Ones Survived, Who’s Leading, and What Are the Real Options in 2025?

BOSTON, June 19, 2025 /PRNewswire/ -- Intrinsic Therapeutics, a medical technology company committed to redefining the standard of care for lumbar discectomy patients with large annular defects by reducing reoperations for reherniations by 81%* with its Barricaid Annular Closure Device, announced today that the International Society for the Advancement of Spine Surgery (ISASS) … [Read more...] about Intrinsic Therapeutics, Inc. Announces That ISASS Has Issued Updated 2025 Recommendations and Coverage Criteria for Barricaid Bone-Anchored Annular Closure

Mountain View, CA – June 16, 2025 – Expanding Innovations™ (EI), a rapidly growing spine company specializing in NON-SCREW-based Expandable Technology, today announced U.S. FDA 510(k) clearance for its N-GAGE™ Lumbar Plate System—the company’s first spinal fixation platform as it continues to broaden its procedure-based solutions. The modular, low-profile … [Read more...] about Expanding Innovations Receives FDA Clearance for N-GAGE™ Lumbar Plate System

In a closely watched case with industry-wide implications, a federal jury in California has ordered Johnson & Johnson MedTech to pay $442.2 million in damages. The verdict follows an antitrust lawsuit filed by Innovative Health, a company focused on reprocessing FDA-cleared electrophysiology catheters—an area that has seen growing interest from hospitals aiming to balance … [Read more...] about J&J Hit with $442M Antitrust Verdict Amid Growing Scrutiny Over MedTech Practices